Latanoprost–netarsudil for previously treated primary open-angle glaucoma or ocular hypertension
Technology appraisal guidance
Reference number: TA1009
Published:
Please note that following on from information received from the company the timelines for this appraisal are to be confirmed.
NICE will continue to monitor the situation and will update interested parties as and when the situation changes.